Mohsen Chitsaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohsen Chitsaz has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Melissa H. BrownBrownBrown
Health and Environment Group, College of Science and Engineering, Flinders University, Bedford Park 5042, South Australia, Australia
2 shared publications Benjamin Harris
Research School of Chemistry, Australian National University, Canberra, ACT, Australia
1 shared publication- Lauren Booth
Research School of Chemistry, Australian National University, Canberra, ACT, Australia
1 shared publication - Megan L. O'MAra
Australian Institute for Bioengineering and Nanotechnology, The University of Queensland St Lucia Queensland Australia
1 shared publication Megan L. O’mAra
Research School of Chemistry, Australian National University, Canberra, ACT, Australia
1 shared publication- Mitchell Tabrum Blyth
Research School of Chemistry, Australian National University, Canberra, ACT 2601, Australia
1 shared publication
Latest Publications
- Open Access
- 31 August 2021
- Published by American Society for Microbiology in mBio
- Vol. 12 (4) , e0167521
A Unique Sequence Is Essential for Efficient Multidrug Efflux Function of the MtrD Protein of Neisseria gonorrhoeae
The historical sexually transmitted infection gonorrhea continues to be a major public health concern with an estimated global annual incidence of 86.9 million cases. N. gonorrhoeae has been identified by the World Health Organization as one of the 12 antimicrobial-resistant bacterial species that poses the greatest risk to human health. As the major efflux pump in gonococci, the MtrD transporter contributes to the cell envelope barrier in this organism and pumps antimicrobials from the periplasm and inner membrane, resulting in resistance.
- 31 August 2021
- Published by American Society for Microbiology in mBio
- Vol. 12 (4) , e0167521
Open AccessA Unique Sequence Is Essential for Efficient Multidrug Efflux Function of the MtrD Protein of Neisseria gonorrhoeae
The historical sexually transmitted infection gonorrhea continues to be a major public health concern with an estimated global annual incidence of 86.9 million cases. N. gonorrhoeae has been identified by the World Health Organization as one of the 12 antimicrobial-resistant bacterial species that poses the greatest risk to human health. As the major efflux pump in gonococci, the MtrD transporter contributes to the cell envelope barrier in this organism and pumps antimicrobials from the periplasm and inner membrane, resulting in resistance.
- Open Access
- 24 December 2019
- Published by American Society for Microbiology in mBio
- Vol. 10 (6)
Multidrug Resistance in Neisseria gonorrhoeae: Identification of Functionally Important Residues in the MtrD Efflux Protein
With over 78 million new infections globally each year, gonorrhea remains a frustratingly common infection. Continuous development and spread of antimicrobial-resistant strains of Neisseria gonorrhoeae , the causative agent of gonorrhea, have posed a serious threat to public health. One of the mechanisms in N. gonorrhoeae involved in resistance to multiple drugs is performed by the MtrD multidrug resistance efflux pump. This study demonstrated that the MtrD pump has a broader substrate specificity than previously proposed and identified a cluster of residues important for drug binding and translocation. Additionally, a permeation pathway for the MtrD substrate progesterone actively moving through the protein was determined, revealing key interactions within the putative MtrD drug binding pockets. Identification of functionally important residues and substrate-protein interactions of the MtrD protein is crucial to develop future strategies for the treatment of multidrug-resistant gonorrhea.
- 24 December 2019
- Published by American Society for Microbiology in mBio
- Vol. 10 (6)
Open AccessMultidrug Resistance in Neisseria gonorrhoeae: Identification of Functionally Important Residues in the MtrD Efflux Protein
With over 78 million new infections globally each year, gonorrhea remains a frustratingly common infection. Continuous development and spread of antimicrobial-resistant strains of Neisseria gonorrhoeae , the causative agent of gonorrhea, have posed a serious threat to public health. One of the mechanisms in N. gonorrhoeae involved in resistance to multiple drugs is performed by the MtrD multidrug resistance efflux pump. This study demonstrated that the MtrD pump has a broader substrate specificity than previously proposed and identified a cluster of residues important for drug binding and translocation. Additionally, a permeation pathway for the MtrD substrate progesterone actively moving through the protein was determined, revealing key interactions within the putative MtrD drug binding pockets. Identification of functionally important residues and substrate-protein interactions of the MtrD protein is crucial to develop future strategies for the treatment of multidrug-resistant gonorrhea.